Generation of glyco‐engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human‐like N‐glycan structure
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Summary: A common argument against using plants as a production system for therapeutic proteins is their inability to perform authentic human N‐glycosylation (i.e. the presence of β1,2‐xylosylation and core α1,3‐fucosylation). In this study, RNA interference (RNAi) technology was used to obtain a targeted down‐regulation of the endogenous β1,2‐xylosyltransferase (XylT) and α1,3‐fucosyltransferase (FucT) genes in Nicotiana benthamiana, a tobacco‐related plant species widely used for recombinant protein expression. Three glyco‐engineered lines with significantly reduced xylosylated and/or core α1,3‐fucosylated glycan structures were generated. The human anti HIV monoclonal antibody 2G12 was transiently expressed in these glycosylation mutants as well as in wild‐type plants. Four glycoforms of 2G12 differing in the presence/absence of xylose and core α1,3‐fucose residues in their N‐glycans were produced. Notably, 2G12 produced in XylT/FucT‐RNAi plants was found to contain an almost homogeneous N‐glycan species without detectable xylose and α1,3‐fucose residues. Plant‐derived glycoforms were indistinguishable from Chinese hamster ovary (CHO)‐derived 2G12 with respect to electrophoretic properties, and exhibited functional properties (i.e. antigen binding and HIV neutralization activity) at least equivalent to those of the CHO counterpart. The generated RNAi lines were stable, viable and did not show any obvious phenotype, thus providing a robust tool for the production of therapeutically relevant glycoproteins in plants with a humanized N‐glycan structure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS12
REED, L. J., & MUENCH, H. (1938) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a118408 · Cited by 19,926
A simple method of estimating 50 per cent end points
Muench, H. (1938) · Medical Entomology and Zoology · Cited by 8,376
Shields, R. L., Lai, J., Keck, R., O'Connell, L. Y., Hong, K., Meng, Y. G., Weikert, S. H. A., & Presta, L. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202069200 · Cited by 1,835
Shinkawa, T., Nakamura, K., Yamane, N., Shoji-Hosaka, E., Kanda, Y., Sakurada, M., Uchida, K., Anazawa, H., Satoh, M., Yamasaki, M., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210665200 · Cited by 1,413
Trkola, A., Purtscher, M., Muster, T., Ballaun, C., Buchacher, A., Sullivan, N., Srinivasan, K., Sodroski, J., Moore, J. P., & Katinger, H. (1996) · Journal of Virology · doi:10.1128/jvi.70.2.1100-1108.1996 · Cited by 1,114
Trkola, A., Kuster, H., Rusert, P., Joos, B., Fischer, M., Leemann, C., Manrique, A., Huber, M., Rehr, M., Oxenius, A., et al. (2005) · Nature Medicine · doi:10.1038/nm1244 · Cited by 502
Self-citationGlycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor
Cox, K. M., Sterling, J. D., Regan, J. T., Gasdaska, J. R., Frantz, K. K., Peele, C. G., Black, A., Passmore, D., Moldovan-Loomis, C., Srinivasan, M., et al. (2006) · Nature Biotechnology · doi:10.1038/nbt1260 · Cited by 421
Giritch, A., Marillonnet, S., Engler, C., van Eldik, G., Botterman, J., Klimyuk, V., & Gleba, Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606631103 · Cited by 419
The Role of Protein Glycosylation in Allergy
Altmann, F. (2007) · International Archives of Allergy and Immunology · doi:10.1159/000096114 · Cited by 393
The Carbohydrate at FcγRIIIa Asn-162
Ferrara, C., Stuart, F., Sondermann, P., Brünker, P., & Umaña, P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510171200 · Cited by 354
Galactose-extended glycans of antibodies produced by transgenic plants
Bakker, H., Bardor, M., Molthoff, J. W., Gomord, V., Elbers, I., Stevens, L. H., Jordi, W., Lommen, A., Faye, L., Lerouge, P., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.031419998 · Cited by 336
Strasser, R., Altmann, F., Mach, L., Glössl, J., & Steinkellner, H. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00150-4 · Cited by 321
Self-citationProduction of a monoclonal antibody in plants with a humanized N‐glycosylation pattern
Schähs, M., Strasser, R., Stadlmann, J., Kunert, R., Rademacher, T., & Steinkellner, H. (2007) · Plant Biotechnology Journal · doi:10.1111/j.1467-7652.2007.00273.x · Cited by 183
Self-citationStrasser, R., Bondili, J. S., Vavra, U., Schoberer, J., Svoboda, B., Glössl, J., Léonard, R., Stadlmann, J., Altmann, F., Steinkellner, H., et al. (2007) · The Plant Cell · doi:10.1105/tpc.107.052985 · Cited by 171
Self-citationDroogenbroeck, B. V., Cao, J., Stadlmann, J., Altmann, F., Colanesi, S., Hillmer, S., Robinson, D. G., Lerberge, E. V., Terryn, N., MONTAGU, M. V., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609997104 · Cited by 135
Self-citationA phase I trial with two human monoclonal antibodies (hMAb 2F5, 2G12) against HIV-1
Armbruster, C., Stiegler, G. M., Vcelar, B. A., Jäger, W. R., Michael, N. L., Vetter, N., & Katinger, H. W. D. (2002) · AIDS · doi:10.1097/00002030-200201250-00012 · Cited by 130
Self-citationSack, M., Paetz, A., Kunert, R., Bomble, M., Hesse, F., Stiegler, G. M., Fischer, R., Katinger, H. W. D., Stoeger, E., & Rademacher, T. (2007) · The FASEB Journal · doi:10.1096/fj.06-5863com · Cited by 103
Self-citationJaeger, G. D., Buys, E. S., Eeckhout, D., Wilde, C. D., Jacobs, A., Kapila, J., Angenon, G., MONTAGU, M. V., Gerats, T., & Depicker, A. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00060.x · Cited by 98
Wilson, I. B. H., & Altmann, F. (1998) · Glycoconjugate Journal · doi:10.1023/a:1006960401562 · Cited by 93
Schuster, M., Jost, W. H., Mudde, G. C., Wiederkum, S., Schwager, C., Janzek, E., Altmann, F., Stadlmann, J., Stemmer, C., & Gorr, G. (2007) · Biotechnology Journal · doi:10.1002/biot.200600255 · Cited by 92
Self-citationBardor, M., Loutelier‐Bourhis, C., Paccalet, T., Cosette, P., Fitchette, A., Vézina, L., Trépanier, S., Dargis, M., Lemieux, R., Lange, C. M., et al. (2003) · Plant Biotechnology Journal · doi:10.1046/j.1467-7652.2003.00041.x · Cited by 91
Strasser, R., Altmann, F., Glössl, J., & Steinkellner, H. (2004) · Glycoconjugate Journal · doi:10.1023/b:glyc.0000045099.29038.04 · Cited by 29
Self-citationAntibody Production in Transgenic Plants
Stöger, E., Schillberg, S., Twyman, R. M., Fischer, R., & Christou, P. (2004) · Humana Press eBooks · doi:10.1385/1-59259-666-5:301 · Cited by 16
Cited by
Strasser, R. (2016) · Glycobiology · doi:10.1093/glycob/cww023 · Cited by 453
Self-citationPlant‐specific glycosylation patterns in the context of therapeutic protein production
Gomord, V., Fitchette, A., Menu‐Bouaouiche, L., Saint‐Jore‐Dupas, C., Plasson, C., Michaud, D., & Faye, L. (2010) · Plant Biotechnology Journal · doi:10.1111/j.1467-7652.2009.00497.x · Cited by 418
Plant-made vaccine antigens and biopharmaceuticals
Daniell, H., Singh, N. D., Mason, H., & Streatfield, S. J. (2009) · Trends in Plant Science · doi:10.1016/j.tplants.2009.09.009 · Cited by 405
Expression systems for therapeutic glycoprotein production
Durocher, Y., & Butler, M. (2009) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2009.10.008 · Cited by 386
Olinger, G. G., Pettitt, J., Kim, D., Working, C., Bohorov, O., Bratcher, B., Hiatt, E., Hume, S. D., Johnson, A. K., Morton, J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213709109 · Cited by 366
Metadata
- Authors
- Strasser, R., Stadlmann, J., Schähs, M., Stiegler, G., Quendler, H., Mach, L., Glössl, J., Weterings, K., Pabst, M., & Steinkellner, H.
- Venue
- Plant Biotechnology Journal
- Publisher
- Wiley
- Published
- 2008-03-13
- Volume
- 6
- Issue
- 4
- Pages
- 392-402
- ISSN
- 1467-7644 (ISSN-L)
- 1467-7652
- OpenAlex
- W1678784904
- Cited by
- 520
- References
- 23
- FWCI
- 24.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.